Shawn A. Messer focuses on Microbiology, Fluconazole, Candida albicans, Corpus albicans and Voriconazole. His Caspofungin, Amphotericin B, Anidulafungin, Fungi imperfecti and Itraconazole investigations are all subjects of Microbiology research. Shawn A. Messer works mostly in the field of Anidulafungin, limiting it down to topics relating to Echinocandin and, in certain cases, Echinocandins.
The Fluconazole study combines topics in areas such as Broth microdilution, Candida glabrata and Etest. As a part of the same scientific family, Shawn A. Messer mostly works in the field of Candida glabrata, focusing on Candida tropicalis and, on occasion, Candida parapsilosis. His Candida albicans study combines topics from a wide range of disciplines, such as Fungemia and Drug resistance.
Microbiology, Fluconazole, Voriconazole, Candida albicans and Broth microdilution are his primary areas of study. His Microbiology study focuses mostly on Caspofungin, Amphotericin B, Candida glabrata, Anidulafungin and Posaconazole. Shawn A. Messer combines subjects such as Candida parapsilosis and Candida krusei, Candida tropicalis with his study of Candida glabrata.
He has researched Fluconazole in several fields, including Itraconazole, Cryptococcus neoformans, Fungi imperfecti, Mycosis and Drug resistance. His study in the field of Ravuconazole also crosses realms of Triazole. His biological study spans a wide range of topics, including Internal medicine and Fungemia.
His main research concerns Microbiology, Candida glabrata, Caspofungin, Anidulafungin and Echinocandin. His work is connected to Candida tropicalis, Fluconazole, Voriconazole, Broth microdilution and Aspergillus, as a part of Microbiology. His work deals with themes such as Amphotericin B, Sentry and Cryptococcus neoformans, which intersect with Fluconazole.
His work on Posaconazole as part of general Voriconazole study is frequently linked to Triazole derivatives and Triazole, therefore connecting diverse disciplines of science. His Anidulafungin study is concerned with the field of Micafungin as a whole. His work carried out in the field of Echinocandin brings together such families of science as Long acting and Echinocandins.
The scientist’s investigation covers issues in Microbiology, Candida glabrata, Caspofungin, Candida tropicalis and Anidulafungin. His study in Microbiology concentrates on Candida parapsilosis, Candida krusei, Micafungin, Candida albicans and Broth microdilution. His Candida albicans research includes elements of Isavuconazonium and Posaconazole.
Candida glabrata is frequently linked to Fluconazole in his study. Shawn A. Messer has included themes like Itraconazole, Azole and Cryptococcus neoformans in his Fluconazole study. Shawn A. Messer works mostly in the field of Caspofungin, limiting it down to topics relating to Aspergillus fumigatus and, in certain cases, Aspergillus niger, Aspergillus flavus, Aspergillus terreus, Aspergillus and Amphotericin B, as a part of the same area of interest.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Attributable Mortality of Nosocomial Candidemia, Revisited
Olafur Gudlaugsson;Olafur Gudlaugsson;Shane Gillespie;Kathleen Lee;Jeff Vande Berg.
Clinical Infectious Diseases (2003)
Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
Barbara D. Alexander;Melissa D. Johnson;Christopher D. Pfeiffer;Cristina Jiménez-Ortigosa.
Clinical Infectious Diseases (2013)
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.
M. A. Pfaller;D. J. Diekema;R. N. Jones;H. S. Sader.
Journal of Clinical Microbiology (2001)
Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases
Sandra S. Richter;Rudolph P. Galask;Shawn A. Messer;Richard J. Hollis.
Journal of Clinical Microbiology (2005)
National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program
Michael A Pfaller;Ronald N Jones;Shawn A Messer;Michael B Edmond.
Diagnostic Microbiology and Infectious Disease (1998)
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
M. A. Pfaller;S. A. Messer;R. J. Hollis;R. N. Jones.
Antimicrobial Agents and Chemotherapy (2002)
Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study
D. J. Diekema;S. A. Messer;A. B. Brueggemann;S. L. Coffman.
Journal of Clinical Microbiology (2002)
Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998
Pfaller;R N Jones;G V Doern;H S Sader.
Antimicrobial Agents and Chemotherapy (2000)
In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance
M. A. Pfaller;L. Boyken;R. J. Hollis;J. Kroeger.
Journal of Clinical Microbiology (2008)
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi
D. J. Diekema;S. A. Messer;R. J. Hollis;R. N. Jones.
Journal of Clinical Microbiology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: